ORF_ID	CONTIG	START	STOP	ORIENTATION	CUT_OFF	PASS_EVALUE	Best_Hit_evalue	Best_Hit_ARO	Best_Identities	ARO	ARO_name	Model_type	SNP	Best_Hit_ARO_category	ARO_category	PASS_bitscore	Best_Hit_bitscore	bit_score	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	LABEL	ID	Model_id
BGC0000549.1|Salivaricin_1	ID=1_1;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.330	0	674	+	Loose	n/a	5.96665e-49	bcrA	44.44	ARO:3002817, ARO:3002817, ARO:3000616, ARO:3000616, ARO:3003749, ARO:3003749, ARO:3003982, ARO:3000489, ARO:3003036, ARO:3003036, ARO:3003748, ARO:3003206, ARO:3003109, ARO:3003109, ARO:3002830, ARO:3002830, ARO:3002829, ARO:3003952, ARO:3002833, ARO:3002833, ARO:3003986, ARO:3003986, ARO:3003980, ARO:3004036, ARO:3000118, ARO:3004035, ARO:3000843, ARO:3000578, ARO:3002819, ARO:3002819, ARO:3003942, ARO:3003942, ARO:3003112, ARO:3003112, ARO:3002828, ARO:3002828, ARO:3003948, ARO:3002827, ARO:3002987, ARO:3003950, ARO:3000300, ARO:3003842, ARO:3004032, ARO:3003206, ARO:3003111, ARO:3003111, ARO:3000300, ARO:3000251, ARO:3002832, ARO:3002829, ARO:3002522, ARO:3004033, ARO:3002832, ARO:3002881, ARO:3000118, ARO:3002882, ARO:3002894, ARO:3002827, ARO:3003949, ARO:3000535	CcrA beta-lactamase, tetA(60), tetB(46), tetA(48), lsaC, otrC, srmB, novA, TaeA, lmrD, abcA, msrC, LlmA 23S ribosomal RNA methyltransferase, salA, vgaD, tetB(60), vgaALC, msrE, tetA(46), mel, lsaB, vgaE, vgaB, lsaE, lsaA, vgaA, oleB, oleC, MUS-1 beta-lactamase, lmrC, MUS-2 beta-lactamase, YojI, tlrC, msrA, sav1866, bcrA, macB, carA, efrB, efrA, msbA	protein homolog model	n/a	efflux pump complex or subunit conferring antibiotic resistance	antibiotic inactivation enzyme; antibiotic target modifying enzyme; determinant of beta-lactam resistance; efflux pump complex or subunit conferring antibiotic resistance; protein(s) and two-component regulatory system modulating antibiotic efflux	1280	162.155	44.669, 79.337, 51.2174, 41.9726, 40.817, 65.855, 24.2534, 69.3218, 42.743, 73.9442, 115.546, 66.2402, 54.6842, 45.0542, 40.817, 40.0466, 40.0466, 48.521, 41.9726, 30.8018, 46.9802, 79.337, 113.62, 71.2478, 61.6178, 62.3882, 29.6462, 23.483, 44.2838, 40.817, 43.8986, 67.0106, 55.8398, 63.5438, 44.669, 69.3218, 64.6994, 41.2022, 162.155, 61.6178, 61.2326, 28.8758, 49.2914, 49.2914, 51.2174, 40.0466, 48.9062, 36.1946, 51.9878, 40.0466, 71.633, 76.6406, 46.595, 71.2478, 53.1434, 63.1586, 87.8113, 72.0182, 67.0106, 78.9518	ATGCAAATAAATATTAATCAACTTTCAAAATCCTATAAAGATAAAACTATCTTGGACAATGTCACTTTTACCATTGAATCGGGTACAATTTGTGGTCTATTAGGGGTTAATGGTGCTGGTAAGTCAACTCTGATGAAAATTCTCTTTGGTTTGGTTCCAAAAAGTGATGGAGAGATTCAATTTGATGGATTATCAAAAAACAAACAATCATTAGGCGCACTAATTGAAACACCTGCTATTTATCATAATCTTTCAGCCTATGACAATTTAAAAACGAAAGCGCTATTATATGACATTCCTGATTCAAAAATTTTTGAAACCTTAGAAATAATCGGTCTTTCTAACACCGGGAAAAAACAAGCGGGTAATTTTTCATTAGGTATGAAGCAACGACTTGGGATTGGTATGGCTATTTTAACTAATCCCCAATTTTTAATTCTAGATGAGCCTACTAATGGACTTGATCCTGATGGTATAAATGAATTACTAGAACTTATTCGTTCCTTGAAAGCAAAAGGGATGACAATTCTGGTTTCCAGTCATCAACTTCTAGAAATTAGTAAGGTTGCTGATCATATTCTTATTCTCGACAAAGGTAGAATTCAATATGATGGTGAAAACAAAAATGTAGATAGTCTTGAGAGACTCTTCTTTAAAATTGTTCATGGGGGTTAG	MQININQLSKSYKDKTILDNVTFTIESGTICGLLGVNGAGKSTLMKILFGLVPKSDGEIQFDGLSKNKQSLGALIETPAIYHNLSAYDNLKTKALLYDIPDSKIFETLEIIGLSNTGKKQAGNFSLGMKQRLGIGMAILTNPQFLILDEPTNGLDPDGINELLELIRSLKAKGMTILVSSHQLLEISKVADHILILDKGRIQYDGENKNVDSLERLFFKIVHGG	MSTIIKTTDLTKMYGSQKSVDHLNINVKQGDIYGFLGRNGAGKTTTIRMLLGLIKPTSGQIEIFGENFFKNKKEILRRIGSIVEVPGFYANLTARENLLINAKIIGIHKKNAIDEVLEIVGLQHETKKLVGKFSLGMKQRLGIARALLHYPELLILDEPTNGLDPIGIKEMRRLIHSLAKERNITIFISSHILSEIEQLVDHVGIIHEGKLLEEIPFDHLKKRNRKYLEFQLSDQNKAVVLMEQHFDIHDYEVHQDGIIRVYSHLGQQGKLNKLFVENGIDVLKITMSEDSLEDYFVKLIGGGTIG	BGC0000549.1|Salivaricin_1#1#675#1#ID=1_1;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.330	gnl|BL_ORD_ID|1|hsp_num:0	345
BGC0000549.1|Salivaricin_2	ID=1_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.327	664	1407	+	Loose	n/a	8.56168	tet(Y)	30.56	ARO:3000182	tet(Y)	protein homolog model	n/a	efflux pump complex or subunit conferring antibiotic resistance	efflux pump complex or subunit conferring antibiotic resistance	750	23.483	23.483	ATGGGGGTTAGTGATATGCAAAAGATATTCTATTCGGAATTGCTCAAATTACGGCATTTAGGAACGACTAAATTCTTAATCATCATACCATTTTTAACCGTTCTTATAGCCTTTTTAATGGGAGGGTTACAGATTTTTGTTCCTTTCTCGGTTTATTGGTGGGAAGCTATCTTTTTATATCTTGTAAATGGTATTTTGTTCATAGTAGATAGACGTTTAGAAGACCAGGCTGGGCATTTTCAAAATGTTACAAATGGATATTTCACTTGGAAAATTAGCTTGATGAAAATGGTGCTTATAGGCATGAGAACATTGCTTGCTAGTTTTTTCTTACTAGCTTTCCTCAGTCTCGTTGCATTTATTTACACAGGTTTTATTCCAATAAATATTCCTAAAACAGCTATTTCCTTAATCTTAATTTGGATGACAACTTTATGGAACATTCCTTTACTTTACCTAATGTCTAAATACATGAGCCAATTCATCTTATTAGCTCTTAATACATTAGTTTGTCTTTTAATAGCCCCCTTTATTGCTCAGAGTCCACTCTGGTTCGTTTTCCCCTATACCTATCATTATAAAATAGCTCAATTTTTATTAAACCTTAAACCATCGGGCGACATTATTACAAATCAAAACCAAACAAGCATTTTGCAAGTGTCACTTATTATTATTTTATCAATGATAATGACATTACTTTTATCATATGTCCTAAAAAGGAGGGAGTCAAATGCTACGGAGTGA	MGVSDMQKIFYSELLKLRHLGTTKFLIIIPFLTVLIAFLMGGLQIFVPFSVYWWEAIFLYLVNGILFIVDRRLEDQAGHFQNVTNGYFTWKISLMKMVLIGMRTLLASFFLLAFLSLVAFIYTGFIPINIPKTAISLILIWMTTLWNIPLLYLMSKYMSQFILLALNTLVCLLIAPFIAQSPLWFVFPYTYHYKIAQFLLNLKPSGDIITNQNQTSILQVSLIIILSMIMTLLLSYVLKRRESNATE	MSKSLITALIVVALDAIGLGLIMPVVPALLNEFVPAEQTAFHYGVFLSLYAFMQVFCAPVLGRLSDRYGRRIILLVSFLGATIDYSIMAAAPVLWVLYIGRIISGVTGATGAIAASIIADTTKQEERARWFGFMGACFGAGMIAGPAIGGVLGDISVHAPFVAGALLNAIAFCLVAFLLPKTPSQPPEGQPAKINLFEGFRFNFAVQGLASFFALFFLMQLIGQAPAALWVIYGEQRLNWDIGTAGVSLAVFGAAHTFVQAVLTGTLSKRLGDRGVLLLGMGADMCGFLLLAFITQSWMVLPAIFMLATGGIGMPALQAIISGLVCDEKQGALQGTLTGLTNITSIIGPVGFTTLYGLTAGQWDGWVWLVAASLYLIAIPLLRQSASLLRS	BGC0000549.1|Salivaricin_2#665#1408#1#ID=1_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.327	gnl|BL_ORD_ID|951|hsp_num:0	402
BGC0000549.1|Salivaricin_8	ID=1_8;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.312	7991	8725	-	Loose	n/a	0.648822	QnrB35	35.9	ARO:3002722, ARO:3002781, ARO:3002736, ARO:3000783, ARO:3003994, ARO:3002753, ARO:3002740, ARO:3002749, ARO:3002219, ARO:3002726, ARO:3002725, ARO:3002773, ARO:3002750	QnrB38, QnrB60, QnrB21, QnrB25, QnrB69, QnrB34, QnrB35, QnrB11, QnrB12, IMP-28, QnrB8, cpaA, cmeA	protein homolog model	n/a	antibiotic target protection protein; determinant of fluoroquinolone resistance	antibiotic inactivation enzyme; antibiotic target protection protein; determinant of aminoglycoside resistance; determinant of beta-lactam resistance; determinant of fluoroquinolone resistance; efflux pump complex or subunit conferring antibiotic resistance	400	26.9498	26.5646, 26.1794, 26.9498, 27.335, 23.8682, 26.9498, 26.9498, 26.5646, 24.6386, 26.5646, 26.5646, 26.9498, 26.9498	ATGGGACGACGGACAAGCATTATAGTGTCTATTTTACTTGTATTGTTGACAGGATGTGGACTAAATAATACGGAGAAAATAGAGTTTTCTAAAACAGATTTTAGACATATAACGTTTAATCACAAAGATTATTCAATCACTGATAATGAAATTTCTAAAGATAATATAAGGAATGTTTTGGTAAAAGACTATAAAGTGATTTGGATTAACTCTCATACAGGAAAAATTCTCTCAAAAGTATCAAATAACAGTTGTACACTGGCAATAATGAATATATTTCAAACAAGTGATAAACTACTGTGTATTGGTATTGATGATAAGTATTTTCAAATTGCTCCGAAAGATCAAACATCTAATCTGTTAAATATATCTAGATTCAGTAGCAAAAACACAAATGTTGAATTGGACAGAGGAGACGATATTTTAATCGATGATAATAATTGTAGGAGAATATTCTACCGAGGAGAAGCTTATTACATAACAAGTGAAGAAGTATCGAGTGATAAGGTAGGAGTTTATATTGACAATTTGGCAGAGGTCAGACTCTTTGATGCTGAGACTGGAAAGAAAATTTCGAATAAGGAGCGTTATGCAATTTATAATAAGGGAGAAGCTAAAGATCGAGTGAATTGGTTTTATGGAGAAGTATATTCCATAAAGAATTCAAAAGATGATGAAGAGTTCCTTGTGGTTAAGATTAATAATGTTTACAGGCGTGCAATGAAGGAAGAGTAG	MGRRTSIIVSILLVLLTGCGLNNTEKIEFSKTDFRHITFNHKDYSITDNEISKDNIRNVLVKDYKVIWINSHTGKILSKVSNNSCTLAIMNIFQTSDKLLCIGIDDKYFQIAPKDQTSNLLNISRFSSKNTNVELDRGDDILIDDNNCRRIFYRGEAYYITSEEVSSDKVGVYIDNLAEVRLFDAETGKKISNKERYAIYNKGEAKDRVNWFYGEVYSIKNSKDDEEFLVVKINNVYRRAMKEE	MALALIGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQMLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG	BGC0000549.1|Salivaricin_8#7992#8726#-1#ID=1_8;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.312	gnl|BL_ORD_ID|276|hsp_num:0	1760
BGC0000549.1|Salivaricin_6	ID=1_6;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.339	5712	6398	-	Loose	n/a	2.30743e-37	vanRM	33.77	ARO:3002919, ARO:3002924, ARO:3002928, ARO:3000828, ARO:3003841, ARO:3002929, ARO:3000858, ARO:3002926, ARO:3000838, ARO:3000832, ARO:3003066, ARO:3000553, ARO:3004054, ARO:3002923, ARO:3000816, ARO:3002927, ARO:3002925, ARO:3004055, ARO:3000833, ARO:3002930, ARO:3002921, ARO:3003728, ARO:3002922	evgA, baeR, evgS, mtrA, armA, vanRA, vanRB, vanRC, vanRD, vanRE, vanRF, vanRG, vanRI, vanRL, smeR, vanRN, vanRO, Pseudomonas aeruginosa CpxR, adeR, arlR, kdpE, Escherichia coli CpxR, vanRM	protein homolog model	n/a	determinant of resistance to glycopeptide antibiotics; antibiotic resistance gene cluster, cassette, or operon; protein(s) conferring antibiotic resistance via molecular bypass	antibiotic resistance gene cluster, cassette, or operon; antibiotic target modifying enzyme; determinant of aminoglycoside resistance; determinant of resistance to glycopeptide antibiotics; efflux pump complex or subunit conferring antibiotic resistance; protein(s) and two-component regulatory system modulating antibiotic efflux; protein(s) conferring antibiotic resistance via molecular bypass	400	129.798	106.301, 100.138, 129.798, 108.612, 76.6406, 95.9005, 24.2534, 100.138, 125.561, 28.4906, 108.227, 100.523, 93.5893, 94.3597, 102.449, 89.3521, 126.331, 96.2857, 32.3426, 76.6406, 105.531, 105.531, 97.0561	GTGCACAAAATTCTTATTGTAGATGATGATATTGATATTTTAAAAATGATGGAATCAGCTCTTCGATTAAAAAACTATAAGGTGGAGACGCGATCAGAAATTAATGTTCCAGTACGAACTCAAGAATTTCAAGGATTTGATGTTATATTATTAGATATTATGATGGCGAACATTGAAGGGACAGATATCTGTAAATGTATCAGAGATTCTATTTCAACTCCAATAATTTTTGTTAGTGCTAAAAATGATGAGAGAGATATTTTAACTGGATTCGACGTAGGTGGTGATGACTACATTACTAAACCCTTTAGTTTAAAACAGCTAGTTGCCAAAGTAGAAGCGAATATTAAGCGTGAGGAGCGTCGTAGGGGGATACACCAAACCTTTACTGATGTTAGACGTGACTTTGGACCTTTAACCTTCTATCTCGAAGAGAATCGTGTTTGTATTGACGGTAAAACGATTCCCTTTACTAGTAGGGAATACGATATTTTGGAACTTTTATCAAGTCATCCTAGAAAAGTATTTACAATTGATGATATTTATACACGTGTTTATGATGAGGATGCGGATGCACTTCTTCGTTCTATTTCGGAATATATTTATCAAATAAGAAAAAAACTATCATGTTATGGTGTAGAACCTATAAAAACCGTTAGAGGTAAGGGGTACCAGTGGAATGTTTAA	VHKILIVDDDIDILKMMESALRLKNYKVETRSEINVPVRTQEFQGFDVILLDIMMANIEGTDICKCIRDSISTPIIFVSAKNDERDILTGFDVGGDDYITKPFSLKQLVAKVEANIKREERRRGIHQTFTDVRRDFGPLTFYLEENRVCIDGKTIPFTSREYDILELLSSHPRKVFTIDDIYTRVYDEDADALLRSISEYIYQIRKKLSCYGVEPIKTVRGKGYQWNV	MRRISILIAEDEEEIADLLAIHLEKEGYDVIKVHDGQEALHVIQAQSIDLIILDIMMPKMDGYEVTRQVRAQYNMPIIFLSAKTSDFDKVHGLVIGGDDYITKPFTPIELVARVNAQLRRSMKLNHPQADDKKSILEFGEIVISPDQRTVFLYGENIGLTPKEFDILYLLASHPKKVYSVENIFQQVWNDAYFGGGNTVMVHIRTLRKKLGEDKRKNKLIKTVWGVGYTFNG	BGC0000549.1|Salivaricin_6#5713#6399#-1#ID=1_6;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.339	gnl|BL_ORD_ID|1069|hsp_num:0	752
BGC0000549.1|Salivaricin_3	ID=1_3;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.320	1394	2044	+	Loose	n/a	6.04123	blt	29.41	ARO:3003006	blt	protein homolog model	n/a	efflux pump complex or subunit conferring antibiotic resistance	efflux pump complex or subunit conferring antibiotic resistance	750	23.8682	23.8682	ATGCTACGGAGTGAGTTACTTAAATTAAAGAATACTACATGTCTCTATCTTATTATCAGTTTTTCTATACTACAAACTCTTTCAATTCCCCTCTATGTAAGATTCGTCCCTAATGGCATTTCTCTAACTAATCTAGCTATCTTATCCTTTTTATGTTATCCTCTATTGACAGCTTTCTTGTCCATTTTAGGAATTGAACAAGAAAAACTCGCTAACCATTATCAAGAAATCTCTAGTTACCCTAAGAAAAGACTCCTGTGGCTAGTAAAACTTTTAATAACAGACTTAGCACTTACCCTACCTTCTTTATTTGGGTGGTTAATCATAAACCTCCTCCTTAAGAATTGGATTAATGGTCTCCTGCTAATGATATCAAGTTGGATGCTAATTGTCTTTCTTAATCATTTTCATTATTTTATACAAGTTTGTCTAAGTAGTACGAGTAACATCGTTATTTCTATAGTTGAAATCATTTTTATTATTTTCGCTAGTAATAAAGTCTTCTTAACTATTCATTGGCTTCCTTTTACTTTTCCTATTAACAGTGTTCTCACTACAGAGTGGACTCCACTCAACACTCTTTCTTATTGGCTTGTAGGGATCACGCTATTATTTATCTATTTTGTAGATTTTAAAGTCAAAGTAGAATGA	MLRSELLKLKNTTCLYLIISFSILQTLSIPLYVRFVPNGISLTNLAILSFLCYPLLTAFLSILGIEQEKLANHYQEISSYPKKRLLWLVKLLITDLALTLPSLFGWLIINLLLKNWINGLLLMISSWMLIVFLNHFHYFIQVCLSSTSNIVISIVEIIFIIFASNKVFLTIHWLPFTFPINSVLTTEWTPLNTLSYWLVGITLLFIYFVDFKVKVE	MKKSINEQKTIFIILLSNIFVAFLGIGLIIPVMPSFMKIMHLSGSTMGYLVAAFAISQLITSPFAGRWVDRFGRKKMIILGLLIFSLSELIFGLGTHVSIFYFSRILGGVSAAFIMPAVTAYVADITTLKERSKAMGYVSAAISTGFIIGPGAGGFIAGFGIRMPFFFASAIALIAAVTSVFILKESLSIEERHQLSSHTKESNFIKDLKRSIHPVYFIAFIIVFVMAFGLSAYETVFSLFSDHKFGFTPKDIAAIITISSIVAVVIQVLLFGKLVNKLGEKRMIQLCLITGAILAFVSTVMSGFLTVLLVTCFIFLAFDLLRPALTAHLSNMAGNQQGFVAGMNSTYTSLGNIFGPALGGILFDLNIHYPFLFAGFVMIVGLGLTMVWKEKKNDAAALN	BGC0000549.1|Salivaricin_3#1395#2045#1#ID=1_3;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.320	gnl|BL_ORD_ID|253|hsp_num:0	1975
BGC0000549.1|Salivaricin_5	ID=1_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.313	4382	5719	-	Loose	n/a	3.67418e-10	vanSM	25.99	ARO:3002936, ARO:3000829, ARO:3002931, ARO:3001549, ARO:3003583, ARO:3000830, ARO:3002934, ARO:3002933, ARO:3002935, ARO:3000549, ARO:3003067, ARO:3001681, ARO:3000217, ARO:3002932, ARO:3000839, ARO:3002938, ARO:3002939, ARO:3002941, ARO:3001327, ARO:3003726, ARO:3000833, ARO:3001550, ARO:3002940, ARO:3002937	baeS, evgS, OXA-363, OXA-362, smeS, adeS, arlS, vanSO, vanSN, cpxA, basS, OXA-278, vanSG, vanSF, vanSE, vanSD, vanSC, vanSB, vanSA, MdtK, blaR1, vanSM, vanSL, vanSI	protein homolog model	n/a	determinant of resistance to glycopeptide antibiotics; antibiotic resistance gene cluster, cassette, or operon; protein(s) conferring antibiotic resistance via molecular bypass	antibiotic inactivation enzyme; antibiotic resistance gene cluster, cassette, or operon; determinant of beta-lactam resistance; determinant of polymyxin resistance; determinant of resistance to glycopeptide antibiotics; efflux pump complex or subunit conferring antibiotic resistance; gene altering cell wall charge; gene modulating beta-lactam resistance; protein(s) and two-component regulatory system modulating antibiotic efflux; protein(s) conferring antibiotic resistance via molecular bypass	700	57.3806	50.8322, 42.743, 45.0542, 26.5646, 45.4394, 51.9878, 25.0238, 46.2098, 54.299, 36.1946, 49.2914, 24.6386, 26.1794, 36.1946, 40.0466, 49.2914, 57.3806, 40.0466, 26.9498, 51.6026, 59.6918, 26.5646, 44.2838, 28.4906	ATGTTTAAACGATACTCTATACGCCAACGTATTTGGCAATTTATTGTTGAAATCATAACTGGTTCTCTTCTTGTGATTACTCTTACCATGGGTATGGGAGTATTGTTGAAACAAACGGGACAACTGGCCTTACCATCTTCTTCGAGTTTCTCGGTTGATTTGGGTGATGCCTCTATATCAGCAATTAACCAAAAAATGAGCCACATTCCTTATGACTATGTAATCTTTGATAAAAAATCAGGTAATATTTTGGGTGGAACCTATCAAAAAAGTGATTTACTAGCATATAAACTTGCAAATAACAATAGTGGAGATGTTGAAAAAAAGGGGGTTACTTATACCTATGCAAGTAACGAGGCAGTATCTATAGTTGTAAGACATAGCACTCTTCCAGAATTTACCAATGCCAGACTACGCCATATTAGTTATAACAAGTTTTCCTATGTAACTGTAATTGTTGGAGTTTTCTTAACAATTGTTATTTCGGTATATCGTTTAGCTAGGGAATATCAGGCTAATTTTAAAGAAATTCAAAAACTAGCATTAAATATGGGAAAATCAACTCTAGATTTTAATAACCATTTAAAAATATTAGAATTCAACAATATTTTGAACAATCTAACAGAAAAAAATAACGAATTAGTATATTTAATAAATAAAGAGAGACATGAAAAAGAAGATTTATCATTTCAAGTAGGAGCACTTTCACATGATGTAAGAACACCCTTGACTGTTCTGAAGGGTAATATAGAGCTTTTGGAAACGACGATTATTTCTAAGGAACAAAGTGAGTTTTTAGAAGCTATGAAGCGTTCATTGTTACGATTTGATAATTATTTTTCTCAAATGATGGATTATACTAAATTATTAAATGAAGATGATCATAAGGAGTATATTTCGTTAGAATTATTTTTATCAGATACATGCTTATTATTAAATGAGTTTGCTAATACGTATGGTGTTTCCTATCATGAAGATATTCAAGTCTATAACTTAGATATTTATATCAATAGTCATGCTTTGTCAAGAGCGATAACTAATATTTTTGTAAATGCATGCCAATATGCTAGAAAAGGTAGTAAACAGGTTTATTTAAACGTATATTTGAAACAAGATAGGTTATGCTTTTCAATATGTAATAATGGGGAACCATTTTCTGAAAGTGCAAAAAAAAATGCGAGTAAGCTATTTTATACAGAGGATTCTGGAAGGACTGGTAAACATTATGGGATAGGCTTAGCTTTTGCTAAAGAAGTAGCTTTCAGACATGATGGAATTTTAGAGTTGAGAAATCCCCCAGGGGGTGGAGCAGAAGTGATTTTACAAATTAAAGTATGA	MFKRYSIRQRIWQFIVEIITGSLLVITLTMGMGVLLKQTGQLALPSSSSFSVDLGDASISAINQKMSHIPYDYVIFDKKSGNILGGTYQKSDLLAYKLANNNSGDVEKKGVTYTYASNEAVSIVVRHSTLPEFTNARLRHISYNKFSYVTVIVGVFLTIVISVYRLAREYQANFKEIQKLALNMGKSTLDFNNHLKILEFNNILNNLTEKNNELVYLINKERHEKEDLSFQVGALSHDVRTPLTVLKGNIELLETTIISKEQSEFLEAMKRSLLRFDNYFSQMMDYTKLLNEDDHKEYISLELFLSDTCLLLNEFANTYGVSYHEDIQVYNLDIYINSHALSRAITNIFVNACQYARKGSKQVYLNVYLKQDRLCFSICNNGEPFSESAKKNASKLFYTEDSGRTGKHYGIGLAFAKEVAFRHDGILELRNPPGGGAEVILQIKV	MAKMRSSFRTKIILLFAVSMLLAGMVTYLLFKGLQLYYHTMIHRGNPLAELRDFIESIGDFNFFFLLFILLSLSVFYILTKPYSAYFDEISTGIQYLALGDFKRRVNIQSNDEFGDIAQAINQASEKLEEAIQRGDFSENSKEQLVVNLAHDLRTPLTSVLGYLDLVLKDEKLTKEQVRHFLTIAFTKSQRLEKLIDELFEITRMNYGMLSIEKKPINLTDLLLQLKEELYPIFEKNGLTARMNTLPHLPVSADGEMLARVFENLLTNANRYGHDGQFVDINGFVDEEEVVVQVVNYGDSIPPNELPYLFDMFYTGDKARTHKEDSTGLGLFIAKNIVEQHNGTVTAESSLIRTVFEVRLPLESAPIDQV	BGC0000549.1|Salivaricin_5#4383#5720#-1#ID=1_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.313	gnl|BL_ORD_ID|1635|hsp_num:0	1328
BGC0000549.1|Salivaricin_12	ID=1_12;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.327	14829	14990	-	Loose	n/a	9.64486	vanL	36.36	ARO:3002910	vanL	protein homolog model	n/a	determinant of resistance to glycopeptide antibiotics; antibiotic resistance gene cluster, cassette, or operon; protein(s) conferring antibiotic resistance via molecular bypass	antibiotic resistance gene cluster, cassette, or operon; determinant of resistance to glycopeptide antibiotics; protein(s) conferring antibiotic resistance via molecular bypass	650	20.0162	20.0162	ATGGCTACAAAAGATTTTAATTTAGACTTGGTAGAAGTCTCAAAAAGCAATACTGGAGCTTCAACTCGAATTACTAGTCATTCATTTTGCTCACAAGCTTGTAAGACTTATAAGATTTTAGGATGTAATTTACTAACACACGGATGTAGGTTTCCTAGGTAG	MATKDFNLDLVEVSKSNTGASTRITSHSFCSQACKTYKILGCNLLTHGCRFPR	MMKLKKIAIIFGGQSSEYEVSLKSTVSVLETLSTCNFEIIKIGIDLGGKWYLTTSNNKDIEYDVWQTDPSLQEIIPCFNNRGFYNKTTNKYFRPDVLFPILHGGTGEDGTLQGVFELMNIPYVGCGVTPSAICMDKYLLHEFAQSVGVKSAPTLIIRTRNCKDEIDKFIEKNDFPIFVKPNEAGSSKGINKVNEPDKLEDALTEAFKYSKSVIIQKAIIGREIGCAVLGNEKLLVGECDEVSLNSDFFDYTEKYQMISAKVNIPASISVEFSNEMKKQAQLLYRLLGCSGLARIDFFLSDNNEILLNEINTLPGFTEHSRYPKMMEAVGVTYKEIITKLINLAEEKYYG	BGC0000549.1|Salivaricin_12#14830#14991#-1#ID=1_12;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.327	gnl|BL_ORD_ID|9|hsp_num:0	349
BGC0000549.1|Salivaricin_10	ID=1_10;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.283	9915	11753	-	Loose	n/a	1.63054e-21	macB	31.91	ARO:3002817, ARO:3002817, ARO:3000616, ARO:3000616, ARO:3003206, ARO:3004035, ARO:3003749, ARO:3000489, ARO:3003036, ARO:3003036, ARO:3003748, ARO:3003206, ARO:3002832, ARO:3002832, ARO:3002830, ARO:3002830, ARO:3002830, ARO:3002829, ARO:3002833, ARO:3003952, ARO:3002833, ARO:3002833, ARO:3003986, ARO:3003986, ARO:3003980, ARO:3004036, ARO:3003749, ARO:3002819, ARO:3002819, ARO:3000784, ARO:3003942, ARO:3003942, ARO:3003112, ARO:3003112, ARO:3002828, ARO:3002828, ARO:3003948, ARO:3000300, ARO:3002832, ARO:3002987, ARO:3003950, ARO:3000118, ARO:3002522, ARO:3004032, ARO:3003109, ARO:3003111, ARO:3003111, ARO:3000300, ARO:3003106, ARO:3000251, ARO:3003109, ARO:3002829, ARO:3003949, ARO:3004033, ARO:3003109, ARO:3002881, ARO:3000118, ARO:3002882, ARO:3002894, ARO:3002827, ARO:3002827, ARO:3000535	srmB, tetA(60), tetB(46), tetA(48), otrC, novA, Erm(42), TaeA, lmrD, abcA, msrC, salA, cmeB, tetB(60), vgaALC, lsaC, tetA(46), mel, vgaD, vgaE, vgaB, lsaE, lsaA, vgaA, oleB, oleC, msrA, lmrC, YojI, tlrC, sav1866, msrE, lsaB, bcrA, macB, carA, efrB, efrA, msbA	protein homolog model	n/a	efflux pump complex or subunit conferring antibiotic resistance	antibiotic target modifying enzyme; determinant of lincosamide resistance; determinant of macrolide resistance; determinant of streptogramin resistance; efflux pump complex or subunit conferring antibiotic resistance; protein(s) and two-component regulatory system modulating antibiotic efflux	1280	95.1301	40.817, 73.9442, 39.6614, 37.3502, 48.1358, 122.865, 46.2098, 143.665, 36.1946, 53.9138, 70.0922, 48.521, 46.595, 37.3502, 25.409, 45.4394, 31.187, 45.8246, 28.4906, 85.1149, 48.521, 30.0314, 46.9802, 52.7582, 65.4698, 97.0561, 45.0542, 42.743, 42.743, 30.0314, 32.7278, 35.8094, 42.3578, 59.6918, 43.1282, 65.4698, 89.3521, 51.9878, 33.8834, 66.6254, 129.413, 51.2174, 120.939, 111.309, 29.261, 49.2914, 47.7506, 41.9726, 30.8018, 31.5722, 44.669, 30.8018, 77.0258, 94.3597, 31.187, 135.961, 46.9802, 111.694, 41.9726, 56.6102, 41.9726, 95.1301	ATGGACAAAATCGAGAGCCTGACTGCAAAACAGTTTATTAGGACTATACTTACTATTCCAAATACATTGAAATTGATTTTCAATATTGAAAAAAGATATGCGATTTATTTAATTATTTTAAATGTTTTGACAGCGATGTCTTCATTGGTTAGTCTTATTATTTTTCAAGAATTGATTAATTCCATTTATTTATCATCAAGTTATTTAATTTTTGTAGTAATTATTTATTTTATTTTGCAAATACTTATCTCATTGTTGGGTCAAGTTGAGAGTTATATTGATGGGAAATTTAATTTCAATCTGTCCTATAGTATTGATAGAAAATTAATGGAAACGATTAACTCCCTTGAGTTAAGTGAACTTGAGCAGTCTGATATGTATAACATTATTGAGAAAATAACTCAAGAAAGCACCTATAAACCATATCAATTATTTAATGCAATCTTACAGGTGCTATCATCAGTAGTTACGATGATATCTAGCTTGATATTCATTGCAACATGGAATATCAGTATGGCTATGTTATTAGGAGTTATTCCTATTATTTCTTTAGTAATGTTTTTGAGGATTGGTCAATTAGAATTTTTGGTTCAATGGGAGAGAGCTAATGAAGAACGGGAGACATGGTACATAAGATATCTACTTACTCATGATTTTTCATTTAAAGAGATTAAGATAAATGATTTAAGTAGTTATTTTATTGAGAAATTTTCAAAATTTAAACAAAGCTTTATCAAGCAGGATCTTAAGATTGCTAGAAAAAAAGCATATTTTAATATAATCTTAGGTATCATATTAAATACAATTAATTTATTTATTGCTTTATCAATTATTATTTATGTAAGAGCAGGAAAACTTCTTATAGGTAATTTTGTTAGTTTAATACAGGTTGTTGCACGAGTGAATAGTTCCTCACAGTCATTAATTCAAAATATCTATATAGTGTATAATACAAGTTTATTTATCGAGCAATTCTTTGAATTTATGGAGACTAATAATGTAAAGAAAGAGAACAAACAAGCTAATATTACGCATCTAAATAAGTTAGATGAAATTAATATTCATCAACTTAACTACAGATACCCAAATACAGAAGATTATGCTTTAAAAGACATCAATTTATCCTTTACAAGGGGTGAATTAGTAGCTATTGTTGGTGGAAATGGCTCAGGTAAGAGTACACTGGTTAAATTAATTTCAGGATTATATACACCATCAAGTGGTGTAATAGAATATGATGGTATGTCCGGAAAATTTTTGGATGATACATTCTATAAAGAGAATATATCAGTACTTTTTCAAGATTATGTTAAGTATGAGTTATCATTAAGAGAGAATATAGGACTGAGTGATACTAATTCGATGAGAAAGGACCACGAAATTATTCAATTATTAGAAAAATTGGGACTAGATTTTCTTAGAGTTAATGGTAGCTATGATCTTGATTTACAATTAGGTACATGGTTTAGAAATGGTAGACAACTGTCAGGAGGGCAGTGGCAAAAAATTGCTCTAGCAAGAACTTTCTTTAAAAAATCATCCATCTATATTTTAGATGAACCAAGTTCGGCCCTTGATTCAATATCTCAAAAAGAAATTTTTGATCATTTCATTGAGTTGTCAAAAAATGATATCTCTATTTTTGTATCACATGATTTAGAAGCAGCTAAAATAGCAGATAGAATTATTGTGATGAGAAAAGGAAAAGTTGAGGACATTGGAACACACAGTGAATTATTTTCACGATGTAAGTATTATAAGGAACTATATGAATCACAGCAGTATGAGGAAATAAATGAATACGGAATTAAAACAACAGGCTATAGAGAAGATTATTGA	MDKIESLTAKQFIRTILTIPNTLKLIFNIEKRYAIYLIILNVLTAMSSLVSLIIFQELINSIYLSSSYLIFVVIIYFILQILISLLGQVESYIDGKFNFNLSYSIDRKLMETINSLELSELEQSDMYNIIEKITQESTYKPYQLFNAILQVLSSVVTMISSLIFIATWNISMAMLLGVIPIISLVMFLRIGQLEFLVQWERANEERETWYIRYLLTHDFSFKEIKINDLSSYFIEKFSKFKQSFIKQDLKIARKKAYFNIILGIILNTINLFIALSIIIYVRAGKLLIGNFVSLIQVVARVNSSSQSLIQNIYIVYNTSLFIEQFFEFMETNNVKKENKQANITHLNKLDEINIHQLNYRYPNTEDYALKDINLSFTRGELVAIVGGNGSGKSTLVKLISGLYTPSSGVIEYDGMSGKFLDDTFYKENISVLFQDYVKYELSLRENIGLSDTNSMRKDHEIIQLLEKLGLDFLRVNGSYDLDLQLGTWFRNGRQLSGGQWQKIALARTFFKKSSIYILDEPSSALDSISQKEIFDHFIELSKNDISIFVSHDLEAAKIADRIIVMRKGKVEDIGTHSELFSRCKYYKELYESQQYEEINEYGIKTTGYREDY	MSLIECKNINRYFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAGSGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGMGGKERSARADKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGKNVMEIIRRLHEAGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKNPEIPASNVGRIQEKASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILEDISSMGTNTISIFPGRGFGDRRSGKIKTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNTDLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTILFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDNANTRVAEKGLAELLKARHGTEDFFMNNSDSIRQMVESTTGTMKLLISSIALISLVVGGIGVMNIMLVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICIIGGLVGVGLSAAVSLVFNHFVTDFPMDISAASVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD	BGC0000549.1|Salivaricin_10#9916#11754#-1#ID=1_10;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.283	gnl|BL_ORD_ID|1142|hsp_num:0	487
BGC0000549.1|Salivaricin_7	ID=1_7;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.333	6373	7989	-	Loose	n/a	2.40127	LRA-8	32.61	ARO:3002487, ARO:3001302	LRA-8, chrB	protein homolog model	n/a	antibiotic inactivation enzyme; determinant of beta-lactam resistance	antibiotic inactivation enzyme; antibiotic target modifying enzyme; determinant of beta-lactam resistance; determinant of macrolide resistance; gene involved in self-resistance to antibiotic	500	26.5646	26.5646, 25.409	ATGAAAAGAATCATAGTTTTATTGTTTTTGGTAACTTGTATTGGGACAGTAGGAGTAAGCTATGCAGATACCGAAGATGAACCAGGTGGTCCGATAGTTTCTACAAAAGTATTTACAGATGGAGAATTACAAAACAAGAGGGAAAACTCTTCAGAAAATAAGAATATCAATTCAGATTCAAATCGATTAAATGATAATAGTAATCAAACTGGCTTAAGGGATGACTTGTCAACTGATAGTGATAATGCTGATAGTACACTGATAAATGAAGAGAGTCAGAGTTTTTGGAATTATCAGTGGGACATGCAGTATGTTACCGATAATGGTAAAAGCTATGAACAATACACTCCTTCTAAGGATATTTCTGTTGGAGTAATCGATTCAGGTATTACTTTGGATCATCCGGATTTAACTAATAGTTTAGGTAGCCATTTAGAAAATTTTGTTCCCCAAAATGGTTTTCATGGTGAAGAACAAGAAGAAACAGGGGTGCTAAATTATGTCAATGATAAATTGGGACATGGTACCGAAGTTGTAGGGCAGATAACAGCGAATGGACGAGTTAAGGGAGTCTCCCCAGGTATCATTGTAAATATTTATCGTGTCTTTGGAGATTCACTTGCTGATCCAAAATGGATTAATAGGGCAATAAGAAAAGCAGCTGATGATGGTAATAAAGTTATTTCACTTAGTATGGGACAATATTTATTAATTTCAGGTTCTTATGATGATGGAACGAATGATTTGGAGACTTATGTTATATATAAAGATGCTATTGATTATGCAAGTGAGAAAGGATCCATTGTAGTTGCTTCCCTAGGGAATGAGGGTTTAAATGAACAAGATAATTCACAAATGTTGCATTATCTTAGCAGTTTTCATCATGTAAAAGAAGCAGGGATAGTAGTGGATGCGCCTTGTATATTCGACCAGGTTGTTGCGGTCGGAGGACTCGATATGTATGGGAATATTTCAGACTTTAGTAACTTCACTGATAAAGCAATCTATGCTCCTGCGGGTTCAACAATTAATCTTAAAAAGTATGGTCCTACAGAATTTTTAAATAAAGGTTTCTATTTAAAAGATTGGATTTTTACAACTAGTTATACAGGGTGGTATCAGTATGTGTATGGAAATTCTTTTGCTGCTCCGAAAGTTGCTTCAGCTATAGCATTAATAGCAGATAAGTATCATATTACGTCACCAGAACAATTGAAACAATTTCTTTTTAAAAACTCACCGACTATTAACGGAAATAAGGTACTAAAATTAACTGATCTTTTGAATGTGGGAAATGCAGATATGTTTCTCTATATGAGTATAGAAAATAGTATATCAAACTTTAATATATATTCTAAGTCGAGTGTTGATCGTTCAAAGATAACACTTCAATTAAAGGATGTCCCAAAACAACTTTCTTATATTATTACCGATACTAGTATTGATCATCTGAATAATAAAATGTTGCCTCCGATGGGTGAGAAGGTAGGCTCTAATATATTGCTAATTGGTTTTTTGATGATTGATTTGTCTGCGTTATTAATTTTTAATAATTTAATTATAAAGTATAATAGTGATAAGGAGGTAGAAAGTGCACAAAATTCTTATTGTAGATGA	MKRIIVLLFLVTCIGTVGVSYADTEDEPGGPIVSTKVFTDGELQNKRENSSENKNINSDSNRLNDNSNQTGLRDDLSTDSDNADSTLINEESQSFWNYQWDMQYVTDNGKSYEQYTPSKDISVGVIDSGITLDHPDLTNSLGSHLENFVPQNGFHGEEQEETGVLNYVNDKLGHGTEVVGQITANGRVKGVSPGIIVNIYRVFGDSLADPKWINRAIRKAADDGNKVISLSMGQYLLISGSYDDGTNDLETYVIYKDAIDYASEKGSIVVASLGNEGLNEQDNSQMLHYLSSFHHVKEAGIVVDAPCIFDQVVAVGGLDMYGNISDFSNFTDKAIYAPAGSTINLKKYGPTEFLNKGFYLKDWIFTTSYTGWYQYVYGNSFAAPKVASAIALIADKYHITSPEQLKQFLFKNSPTINGNKVLKLTDLLNVGNADMFLYMSIENSISNFNIYSKSSVDRSKITLQLKDVPKQLSYIITDTSIDHLNNKMLPPMGEKVGSNILLIGFLMIDLSALLIFNNLIIKYNSDKEVESAQNSYCR	MSKSSLKGLVLLALVAAIAAPSWAARKEKPAAKAPPCEQCAVWNADQEPFKIWGNTYYVGVKGLSSVLVTSDWGHVLLDGGLPESAPKIAANIEKLGFKVTDVKAILSSHVHADHAGGIAELQRRSGAKVYQRRPSDQVLRTGKPDPGDPQLARAGPIPPVENVWVVHDEELLGLGPTRFTVVATPGHTPGGTSWAWESCEGAQCLKIVYADSLNAVSAEGFRFTASTTYPNVLQDLEQSFKRVESLPCDVIVSVHPEQSDFFPRMAKRVDGKPESIKDPEGCKRYVAGARERLALRVASEKQGS	BGC0000549.1|Salivaricin_7#6374#7990#-1#ID=1_7;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.333	gnl|BL_ORD_ID|1710|hsp_num:0	718
